Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib with Chemoradiation for Head and Neck Cancer
NCT00581971Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2002
- Primary completion
- Dec 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in head and neck squamous cell carcinoma (HNSCC), sponsored by University of Alabama at Birmingham. Started Sep 2002; status: completed.
02
Drugs
celecoxib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00581971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00581971.